Antibody Screening - Unravelling the full potential of entire immune repertoires (millions of B cells) VERAXA´s unique platform can combine the assessment of antibody binding with its functional capabilities in 1 single screening step, using a proprietary droplet-based microfluidic screening workstation.


Biotechnology

Veraxa Biotech

Christoph Antz

Yasemin Doeger

Heinz Schwer Ph.D.

Marian Weiss

Anna Pryszlak

Torsten Bürgermeister

Edward A. Lemke

Steffen Runz

Paul F. Sauter

Christine Köhler

Michael Ruppert

Christoph A. Merten

Lars Hufnagel

The board of directors at Veraxa Biotech has a history of experience in managing and developing life sciences companies. Members have experience working in industries such as healthcare, research and development, and technology. They also have a variety of educational backgrounds, including physical chemistry and molecular biology.

Board of Directors

Leadership Team

Founding Team

Board of Directors

About

Team members

Other teams at Veraxa Biotech

Leadership Team

Founding Team